Publications

Oh, Stephen T., Moshe Talpaz, Aaron T. Gerds, Vikas Gupta, Srdan Verstovsek, Ruben Mesa, Carole B. Miller, et al. “ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial.” Blood Adv 4, no. 18 (September 22, 2020): 4282–91. https://doi.org/10.1182/bloodadvances.2020002662.

PMID
32915978
Full Text

Thom, Howard, Jeroen Jansen, Jason Shafrin, Lauren Zhao, George Joseph, Hung-Yuan Cheng, Subhajit Gupta, and Nirmish Shah. “Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis.” Bmj Open 10, no. 9 (September 17, 2020): e034147. https://doi.org/10.1136/bmjopen-2019-034147.

PMID
32948541
Full Text

Thachil, Jecko, Nicole P. Juffermans, Marco Ranucci, Jean M. Connors, Theodore E. Warkentin, Thomas L. Ortel, Marcel Levi, Toshiaki Iba, and Jerrold H. Levy. “ISTH DIC subcommittee communication on anticoagulation in COVID-19.” J Thromb Haemost 18, no. 9 (September 2020): 2138–44. https://doi.org/10.1111/jth.15004.

PMID
32881336
Full Text

Hodges, Jason R., Shannon M. Phillips, Sarah Norell, Chinonyelum Nwosu, Hamda Khan, Lingzi Luo, Sherif M. Badawy, et al. “Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.” Blood Advances 4, no. 18 (September 2020): 4463–73. https://doi.org/10.1182/bloodadvances.2020001701.

PMID
32941646
Full Text

Stewart, Kearsley A., Monika Parshad-Asnani, Ambroise Wonkam, John Bollinger, Valentina Ngo Bitoungui, Edmond Wonkam-Tingang, Jill Powell, et al. “"Pain is Subjective": A Mixed-Methods Study of Provider Attitudes and Practices Regarding Pain Management in Sickle Cell Disease Across Three Countries.” Journal of Pain and Symptom Management, September 2020. https://doi.org/10.1016/j.jpainsymman.2020.08.029.

PMID
32889040
Full Text

Ortel, Thomas L., Sreelatha Meleth, Diane Catellier, Mark Crowther, Doruk Erkan, Paul R. Fortin, David Garcia, et al. “Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis.” J Thromb Haemost 18, no. 9 (September 2020): 2274–86. https://doi.org/10.1111/jth.14936.

PMID
32484606
Full Text

Knisely, Mitchell R., Norma Pugh, Barbara Kroner, Rita Masese, Victor Gordeuk, Allison A. King, Sharon M. Smith, et al. “Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.” Am J Hematol 95, no. 9 (September 2020): 1066–74. https://doi.org/10.1002/ajh.25880.

PMID
32449965
Full Text

Linton, Elizabeth A., Dania A. Goodin, Jane S. Hankins, Julie Kanter, Liliana Preiss, Jena Simon, Kimberly Souffront, et al. “A Survey-Based Needs Assessment of Barriers to Optimal Sickle Cell Disease Care in the Emergency Department.” Annals of Emergency Medicine 76, no. 3S (September 2020): S64–72. https://doi.org/10.1016/j.annemergmed.2020.08.013.

PMID
32928465
Full Text

Isaacs, James, Ian J. Welsby, Jacob N. Schroder, and Oluwatoyosi A. Onwuemene. “Activated Coagulation Time and Hepcon Protamine Titration Device to Manage Unfractionated Heparin During Cardiopulmonary Bypass in a Hemophilia A Patient on Emicizumab.” J Cardiothorac Vasc Anesth, August 27, 2020. https://doi.org/10.1053/j.jvca.2020.08.058.

PMID
32928650
Full Text

Isaacs, James, Ian J. Welsby, Jacob N. Schroder, and Oluwatoyosi A. Onwuemene. “Activated Coagulation Time and Hepcon Protamine Titration Device to Manage Unfractionated Heparin During Cardiopulmonary Bypass in a Hemophilia A Patient on Emicizumab.” J Cardiothorac Vasc Anesth, August 27, 2020. https://doi.org/10.1053/j.jvca.2020.08.058.

PMID
32928650
Full Text

Pages